Highlights: -The future of renal denervation rests on selecting the right patient -FAME II trial preliminary results show FFR-guided angioplasty superior to medical therapy alone -Alain Cribier: 10 years of TAVI -Profile: Bernard Chevalier
[pdfviewer width=”100%” height=”940px” beta=”true”]http://cardiovascularnews.com/wp-content/uploads/sites/14/2016/06/Cardiovascular-News-26-EU.pdf[/pdfviewer]
